- Recommendations for the management of patients with homozygous familial hypercholesterolaemia: overview of a new European Atherosclerosis Society consensus statement.
Published 2014 (European Atherosclerosis Society )
- [Diagnostic and treatment of familial hypercholesterolemia (FH) in adult: guidelines from the New French Society of Atherosclerosis (NSFA)].
Published 2013 (New French Society of Atherosclerosis (NSFA))
- HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom.
Published 2016 (HEART UK Medical Scientific and Research Committee)
- Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel.
Published 2016 (International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel)
- Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.
Published 2016 (Expert panel)
lunes, 29 de mayo de 2017
PCSK9|https://phgkb.cdc.gov/GAPPKB/phgHome.do|Updates on Specific Diseases
From Guideline Database
This database contains updated guidelines, policies and recommendations on genomic research and practice, as provided by professional organizations, federal advisory groups, expert panels and policy groups.